Transaction Details:

Hash a3149ea666028dc92c3e97a2bcc5d0e7f58043e54b9df555df25e11b526b8e23
Blockhash 794f0f2a69cf1a862eaa78625179cd8d7347a094f93fae3fa614a2cbed5cd65a
Blocktime 2019-11-22 17:47
Confirmations 48626

Inputs

Index Previous Output Address
0 11ce9df47f001c9666d15610ce6fe97dfd250d2be7475585f977660ea3cf5a0c:0 2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd

Outputs

Index Redeemed in Address Amount
0 Not yet redeemed N/A 0 CBL
1 Not yet redeemed 2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd 99.99982594 CBL
{
"txid": a3149ea666028dc92c3e97a2bcc5d0e7f58043e54b9df555df25e11b526b8e23,
"time": 1574444848,
"blocktime": 1574444848,
"blockhash": 794f0f2a69cf1a862eaa78625179cd8d7347a094f93fae3fa614a2cbed5cd65a,
"confirmations": 48626,
"vin ": [
{
"sequence": 4294967295
"vout": 0
"txid": 11ce9df47f001c9666d15610ce6fe97dfd250d2be7475585f977660ea3cf5a0c
"scriptSig": {'hex': '4830450221009f914590b51d3ced3b0de88a50af29d6982a6848d4e5922e49e517de2a6119b502204c033506a0d3b9f7e32279789f3f9fddc8477bc5d24416674c64092ea34bd1d3012103f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38', 'asm': '30450221009f914590b51d3ced3b0de88a50af29d6982a6848d4e5922e49e517de2a6119b502204c033506a0d3b9f7e32279789f3f9fddc8477bc5d24416674c64092ea34bd1d301 03f4157f5bbcf4594cb612f878fa622f4fa99713ebd638179751679d259fb49e38'}
}
],
"vout ": [
{
"items": [
{'streamref': '22580-300-49565', 'publishers': ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd'], 'name': 'iscc', 'createtxid': '9dc120f0f3ba1bf3cc53010a0af74f164961f37595bdd9a89b5064e60304c070', 'keys': ['CCds1AecJqPgC', 'CT1pxbnSQeFD4', 'CDU5JosaqdqDh', 'CRBzdATD8kP4q'], 'data': {'json': {'tophash': '41b9e9ead56ed0f779e8b4715e6f28008f54d138a98bf4bcd1b4c5f7733d66e1', 'title': 'a report of rabbit syndrome who benefited from sigma 1 agonist fluvoxamine', 'meta': [{'schema': 'schema.org', 'data': {'encoding': [{'contentUrl': 'http://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2019.17.1.134', '@type': 'MediaObject', 'encodingFormat': 'application/pdf'}], '@type': 'ScholarlyArticle', 'name': 'A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine', 'publisher': {'@type': 'Organization', 'name': 'Korean College of Neuropsychopharmacology'}, '@context': 'http://schema.org/', 'license': 'cc-by-nc', 'genre': 'journal-article', 'author': [{'@type': 'Person', 'name': 'Yakup Albayrak'}, {'@type': 'Person', 'name': 'Murat Beyazyüz'}, {'@type': 'Person', 'name': 'Özlem Abbak'}, {'@type': 'Person', 'name': 'Ece Altındağ'}], 'datePublished': '2019-02-28', 'identifier': [{'@type': 'PropertyValue', 'value': '10.9758/cpn.2019.17.1.134', 'propertyID': 'DOI'}, {'@type': 'PropertyValue', 'value': 'CCds1AecJqPgC-CT1pxbnSQeFD4-CDU5JosaqdqDh-CRBzdATD8kP4q', 'propertyID': 'ISCC'}]}, 'mediatype': 'application/ld+json'}]}}, 'type': 'stream'}
],
"value": 0
"n": 0
"scriptPubKey": {
"hex": 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
"asm": 73706b65164ff70a0a0153ccf31bbaf3f020c19d OP_DROP 73706b6b43436473314165634a71506743 OP_DROP 73706b6b4354317078626e535165464434 OP_DROP 73706b6b434455354a6f73617164714468 OP_DROP 73706b6b4352427a64415444386b503471 OP_DROP 73706b6602 OP_DROP OP_RETURN 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
"type": nulldata
}
},
{
"value": 99.99982594
"n": 1
"scriptPubKey": {
"reqSigs": 1
"addresses": ['2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd']
"hex": 76a91470f3924b82ad8ba9ca4b38ee85a83bd99c142f9f88ac
"asm": OP_DUP OP_HASH160 70f3924b82ad8ba9ca4b38ee85a83bd99c142f9f OP_EQUALVERIFY OP_CHECKSIG
"type": pubkeyhash
}
}
]
}